|
1
|
Rodríguez-Vicente AE, Díaz MG and
Hernández-Rivas JM: Chronic lymphocytic leukemia: A clinical and
molecular heterogenous disease. Cancer Genet. 206:49–62. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alhourani E, Rincic M, Othman MA, Pohle B,
Schlie C, Glaser A and Liehr T: Comprehensive chronic lymphocytic
leukemia diagnostics by combined multiplex ligation dependent probe
amplification (MLPA) and interphase fluorescence in situ
hybridization (iFISH). Mol Cytogenet. 7:792014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Döhner H, Stilgenbauer S, Benner A,
Leupolt E, Kröber A, Bullinger L, Döhner K, Bentz M and Lichter P:
Genomic aberrations and survival in chronic lymphocytic leukemia. N
Engl J Med. 343:1910–1916. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gunn SR, Hibbard MK, Ismail SH,
Lowery-Nordberg M, Mellink CH, Bahler DW, Abruzzo LV, Enriquez EL,
Gorre ME, Mohammed MS and Robetorye RS: Atypical 11q deletions
identified by array CGH may be missed by FISH panels for prognostic
markers in chronic lymphocytic leukemia. Leukemia. 23:1011–1017.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Greipp PT, Smoley SA, Viswanatha DS,
Frederick LS, Rabe KG, Sharma RG, Slager SL, Van Dyke DL, Shanafelt
TD, Tschumper RC and Zent CS: Patients with chronic lymphocytic
leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a
very poor prognosis. Br J Haematol. 163:326–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Campregher PV and Hamerschlak N: Novel
prognostic gene mutations identified in chronic lymphocytic
leukemia and their impact on clinical practice. Clin Lymphoma
Myeloma Leuk. 14:271–276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rossi D, Fangazio M, Rasi S, Vaisitti T,
Monti S, Cresta S, Chiaretti S, Del Giudice I, Fabbri G, Bruscaggin
A, et al: Disruption of BIRC3 associates with fludarabine
chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.
Blood. 119:2854–2862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rossi D, Fangazio M and Gaidano G: The
spectrum of genetic defects in chronic lymphocytic leukemia.
Mediterr J Hematol Infect Dis. 4:e20120762012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rossi D, Rasi S, Spina V, Bruscaggin A,
Monti S, Ciardullo C, Deambrogi C, Khiabanian H, Serra R, Bertoni
F, et al: Integrated mutational and cytogenetic analysis identifies
new prognostic subgroups in chronic lymphocytic leukemia. Blood.
121:1403–1412. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Puiggros A, Blanco G and Espinet B:
Genetic abnormalities in chronic lymphocytic leukemia: Where we are
and where we go. BioMed Res Int. 2014:4359832014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hallek M, Cheson BD, Catovsky D,
Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ,
Montserrat E, Rai KR and Kipps TJ: International Workshop on
Chronic Lymphocytic Leukemia: Guidelines for the diagnosis and
treatment of chronic lymphocytic leukemia: A report from the
International Workshop on Chronic Lymphocytic Leukemia updating the
National Cancer Institute-Working Group 1996 guidelines. Blood.
111:5446–5456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Othman MA, Rincic M, Melo JB, Carreira IM,
Alhourani E, Hunstig F, Glaser A and Liehr T: Novel cryptic
three-way translocation t(2;9;18)(p23.2;p21.3;q21.33) with deletion
of tumor suppressor genes in 9p21.3 and 13q14 in a T-cell acute
lymphoblastic leukemia. Leukemia Res Treat. 2014:3571232014.
|
|
13
|
Rossi D, Ciardullo C, Spina V and Gaidano
G: Molecular bases of chronic lymphocytic leukemia in light of new
treatments. Immunol Lett. 155:51–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cortese D, Sutton LA, Cahill N, Smedby KE,
Geisler C, Gunnarsson R, Juliusson G, Mansouri L and Rosenquist R:
On the way towards a ‘CLL prognostic index’: Focus on TP53, BIRC3,
SF3B1, NOTCH1 and MYD88 in a population-based cohort. Leukemia.
28:710–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morgan JA, Yin Y, Borowsky AD, Kuo F,
Nourmand N, Koontz JI, Reynolds C, Soreng L, Griffin CA,
Graeme-Cook F, et al: Breakpoints of the t(11;18)(q21;q21) in
mucosa-associated lymphoid tissue (MALT) lymphoma lie within or
near the previously undescribed gene MALT1 in chromosome 18. Cancer
Res. 59:6205–6213. 1999.PubMed/NCBI
|
|
16
|
Shao L, Kang SH, Li J, Hixson P, Taylor J,
Yatsenko SA, Shaw CA, Milosavljevic A, Chang CC, Cheung SW and
Patel A: Array comparative genomic hybridization detects
chromosomal abnormalities in hematological cancers that are not
detected by conventional cytogenetics. J Mol Diagn. 12:670–679.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Specchia G, Albano F, Anelli L, Storlazzi
CT, Monaco M, Capalbo S, Rocchi M and Liso V: Concomitant tetrasomy
3q and trisomy 18 in CD5(−), CD13(+) chronic lymphocytic leukemia.
Cancer Genet Cytogenet. 133:160–163. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kebriaei P, Anastasi J and Larson RA:
Acute lymphoblastic leukaemia: Diagnosis and classification. Best
Pract Res Clin Haematol. 15:597–621. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ryan KM, Ernst MK, Rice NR and Vousden KH:
Role of NF-kappaB in p53-mediated programmed cell death. Nature.
404:892–897. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Keller U, Huber J, Nilsson JA, Fallahi M,
Hall MA, Peschel C and Cleveland JL: Myc suppression of Nfkb2
accelerates lymphomagenesis. BMC Cancer. 10:348–358. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu F, Bardhan K, Yang D, Thangaraju M,
Ganapathy V, Waller JL, Liles GB, Lee JR and Liu K: NF-κB directly
regulates Fas transcription to modulate Fas-mediated apoptosis and
tumor suppression. J Biol Chem. 287:25530–25540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cox MC, Panetta P, Lo-Coco F, Del Poeta G,
Venditti A, Maurillo L, Del Principe MI, Mauriello A, Anemona L,
Bruno A, et al: Chromosomal aberration of the 11q23 locus in acute
leukemia and frequency of MLL gene translocation: Results in 378
adult patients. Am J Clin Pathol. 122:298–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Monni O and Knuutila S: 11q deletions in
hematological malignancies. Leuk Lymphoma. 40:259–266. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Strefford JC, Sutton LA, Baliakas P,
Agathangelidis A, Malčíková J, Plevova K, Scarfó L, Davis Z,
Stalika E, Cortese D, et al: Distinct patterns of novel gene
mutations in poor-prognostic stereotyped subsets of chronic
lymphocytic leukemia: The case of SF3B1 and subset #2. Leukemia.
27:2196–2199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rose-Zerilli MJ, Forster J, Parker H,
Parker A, Rodríguez AE, Chaplin T, Gardiner A, Steele AJ, Collins
A, Young BD, et al: ATM mutation rather than BIRC3 deletion and/or
mutation predicts reduced survival in 11q-deleted chronic
lymphocytic leukemia: Data from the UK LRF CLL4 trial.
Haematologica. 99:736–742. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goorha S, Glenn MJ, Drozd-Borysiuk E and
Chen Z: A set of commercially available fluorescent in-situ
hybridization probes efficiently detects cytogenetic abnormalities
in patients with chronic lymphocytic leukemia. Genet Med. 6:48–53.
2004. View Article : Google Scholar : PubMed/NCBI
|
